Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Worldwide Over-the-Counter Drugs Industry to 2025 - Featuring Bayer, Pfizer & Sanofi Among Others

Research and Markets Logo

News provided by

Research and Markets

Sep 07, 2020, 14:15 ET

Share this article

Share toX

Share this article

Share toX

DUBLIN, Sept. 7, 2020 /PRNewswire/ -- The "Global Over-the-Counter Drugs Market: Consumer Behavior Analysis by Countries, Buying Pattern Analysis, Demographics, Trends Analysis, Survey Findings and Results, Leading Companies and their Market Strategies" report has been added to ResearchAndMarkets.com's offering.

The global over-the-counter drug market was valued at USD 141.6 billion in 2018 and it is expected to grow with a CAGR of 7.6% over the forecast period of 2019-2025.

The key players in the OTC drugs market are leveraging the brand equity of the major products during their patent period to improve sales and revenue. This, in turn, is majorly driving the global over-the-counter drugs market. Moreover, the growing trend of self-medication among the population is also contributing to the growing demand for OTC drugs. The patients continue to buy a particular medicine following an initial prescription from the doctor. In addition, factors such as increasing globalization, shrinking new product pipeline, increasing cost of new drug discovery, stringent safety rules of FDA, and entry of new players in the market are further augmenting the growth of the global over-the-counter drugs market.

The survey conducted by The author found that majority of people across the world take advice from the pharmacist before buying an OTC medication. The relation between the local pharmacists and the consumers or patients plays an important role in the higher trust of the consumer on pharmacists. The frequent visits to the local pharmacy stores lead to higher interaction with the pharmacists. This, in turn, improves the relationship between consumers and pharmacists, which ultimately impacts the decision making of the consumers. Moreover, the pharmacists are easy to access than the professional physicians or doctors. If a patient wants to consult a doctor regarding a common health issue, he or she has to get an appointment first, and sometimes doctors could charge fees for their counseling or advice. Thus, people tend to take advice from pharmacists rather than doctors regarding common health conditions and their OTC treatment.

The United States, China, and Germany among Top Markets for Over-The-Counter Drugs

According to the findings in the report, the United States of America and China along with countries in Europe are the best markets for over-the-counter drugs. Europe and North America together make nearly 60% of the total sales of OTC drugs in the world. The US is the leading country in terms of sales in the global over-the-counter drug market followed by China and Germany. The increasing trend of self-medication and rising need to cut healthcare costs are the major drivers for the sale of OTC drugs in western countries. Moreover, the higher geriatric population and availability of numerous products in the community pharmacies are the major factors contributing to the growth of Chinese OTC drugs market. On the flip side, the sale of over-the-counter drugs in developing countries such as India is anticipated to grow rapidly. Factors including improving economic and healthcare conditions and higher prevalence of common ailments are majorly influencing the sale of over-the-counter drugs in developing countries.

North America Generated the Highest Revenue from Over-The-Counter Drugs

In terms of geography, North America generated the highest revenue in the global OTC drugs market. The growing trend of self-medication among the population in the region drives the growth of the over-the-counter drugs market in North America. Patients purchase OTC drugs from a nearby retailer for any visible mild symptoms without visiting a medical institution. Moreover, favorable reimbursement policies support the growth of the OTC drug market in the North American region. Several insurance policies available in the US offer some coverage for OTC drugs. Moreover, the Asia Pacific region is projected to grow with the fastest rate owing to the increasing number of approvals given for several prescription drugs to be sold as OTC drugs. For instance, in Japan, the antipyretic analgesic Loxonin S and Alesion, treatment for allergic rhinitis were approved for OTC sales in 2010.

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Market Overview & Competitiveness
3.1. Introduction
3.2. DRO Analysis
3.2.1. Drivers
3.2.1.1. Growing trend of self medication
3.2.1.2. Higher brand equity of Drugs
3.2.1.3. Increasing cost of new Drugs development
3.2.2. Restraints
3.2.2.1. Side effects of overuse
3.2.3. Opportunities
3.2.3.1. Growing number of patent expiration of Drugs
3.3. Analysis of COVID-19 impact on the Over-the-Counter Drugs Market
3.3.1. Impact of COVID-19 on the Sales of Over-the-Counter Drugs Market 2020-2026
3.3.2. Impact of COVID-19 on the Over-the-Counter Drugs Market by Region
3.3.2.1. North America
3.3.2.2. Europe
3.3.2.3. Asia Pacific
3.3.2.4. RoW
3.4. Porter's Five Forces Analysis
3.5. Value Chain Analysis of Over-the-Counter Drugs Market
3.6. Product Placement and Positioning Matrices
3.6.1. Growth Share Matrix
3.6.2. Product Placement Matrix
3.6.3. Product Life Cycle Analysis

4. Company Profiles and Competitive Landscape
4.1. Competitive Landscape and Top Recent Developments
4.2. Leading Company Profiles and Their Products in the Global Over-the-Counter Drugs
4.2.1. Johnson & Johnson Services, Inc.
4.2.1.1. Overview
4.2.1.2. Company Snapshot
4.2.1.3. Financial Snapshot
4.2.1.4. Product Portfolio
4.2.1.5. Recent Developments
4.2.2. Takeda Pharmaceutical Company Ltd.
4.2.2.1. Overview
4.2.2.2. Company Snapshot
4.2.2.3. Financial Snapshot
4.2.2.4. Product Portfolio
4.2.2.5. Recent Developments
4.2.3. Bayer AG
4.2.3.1. Overview
4.2.3.2. Company Snapshot
4.2.3.3. Financial Snapshot
4.2.3.4. Product Portfolio
4.2.3.5. Recent Developments
4.2.4. Pfizer Inc.
4.2.4.1. Overview
4.2.4.2. Company Snapshot
4.2.4.3. Financial Snapshot
4.2.4.4. Product Portfolio
4.2.4.5. Recent Developments
4.2.5. Sanofi S.A.
4.2.5.1. Overview
4.2.5.2. Company Snapshot
4.2.5.3. Financial Snapshot
4.2.5.4. Product Portfolio
4.2.5.5. Recent Developments
4.2.6. GlaxoSmithKline Plc
4.2.6.1. Overview
4.2.6.2. Company Snapshot
4.2.6.3. Financial Snapshot
4.2.6.4. Product Portfolio
4.2.6.5. Recent Developments
4.2.7. Novartis International AG
4.2.7.1. Overview
4.2.7.2. Company Snapshot
4.2.7.3. Financial Snapshot
4.2.7.4. Product Portfolio
4.2.7.5. Recent Developments
4.2.8. Cipla Limited
4.2.8.1. Overview
4.2.8.2. Company Snapshot
4.2.8.3. Financial Snapshot
4.2.8.4. Product Portfolio
4.2.8.5. Recent Developments
4.2.9. Dr. Reddy's Laboratories
4.2.9.1. Overview
4.2.9.2. Company Snapshot
4.2.9.3. Financial Snapshot
4.2.9.4. Product Portfolio
4.2.9.5. Recent Developments
4.2.10. Himalaya Global Holdings Ltd.
4.2.10.1. Overview
4.2.10.2. Company Snapshot
4.2.10.3. Financial Snapshot
4.2.10.4. Product Portfolio
4.2.10.5. Recent Developments

5. Global Over-the-Counter Drugs Market, by Segmentation
5.1. Global Over-the-Counter Drugs Market, by Route of Administration
5.1.1. Oral
5.1.2. Topical
5.1.3. Parenteral
5.1.4. Others
5.2. Global Over-the-Counter Drugs Market, by Therapeutic Class
5.2.1. Pain Medications
5.2.2. Gastrointestinal Drugs
5.2.3. Dietary Supplements
5.2.4. Respiratory Drugs
5.2.5. Others

6. Global Over-the-Counter Drugs Market, by Region
6.1. Overview
6.2. North America Over-the-Counter Drugs Market
6.3. Europe Over-the-Counter Drugs Market
6.4. Asia-Pacific Over-the-Counter Drugs Market
6.5. RoW Over-the-Counter Drugs Market

For more information about this report visit https://www.researchandmarkets.com/r/djqqd7

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.